4D MOLECULAR THERAPEUTICS INC. - COMMON STOCK
31.86
28-March-24 15:59:55
15 minutes delayed
Stocks
-4.01
-11.18%
Today's range
30.25 - 34.20
ISIN
N/A
Source
NASDAQ
-
28 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
04 Mar 2024 08:00:00 By Nasdaq GlobeNewswire
-
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
29 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
12 Feb 2024 08:00:00 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
06 Feb 2024 23:27:14 By Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
05 Feb 2024 16:05:00 By Nasdaq GlobeNewswire
-
03 Feb 2024 17:00:00 By Nasdaq GlobeNewswire
-
23 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
4DMT Highlights Recent Clinical Pipeline Progress, Near-Term Milestones and Organizational Updates
04 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
03 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
21 Dec 2023 08:00:00 By Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
15 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
4DMT Reports Third Quarter 2023 Financial Results and Operational Highlights
09 Nov 2023 16:19:53 By Nasdaq GlobeNewswire
-
01 Nov 2023 16:00:00 By Nasdaq GlobeNewswire
-
30 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
25 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
23 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
4DMT Appoints Uneek Mehra as Chief Financial and Business Officer
12 Sep 2023 16:05:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >